Can exercise lower breast cancer risk? Oncologist explains which workouts women should focus on

India, Sept. 18 -- Breast cancer has many risk factors, from age to genetics. While some cannot be controlled, others can be managed through conscious lifestyle choices. Everyday habits are generally ... और पढ़ें

Which Animal Gives Birth After 114 Days? Here's the Surprising Answer

India, Sept. 18 -- Have you ever wondered how long animals carry their babies before giving birth? While some animals have surprisingly short pregnancies, others remain pregnant for months. If you are... और पढ़ें

"This enemy silently infiltrates our villages and homes...": BJP President Nitin Nabin launches 'Nasha Mukt' blitz in Punjab following Gulzar Singh's death

Pathankot, Sept. 18 -- Addressing a gathering in Pathankot, BJP National President Nitin Nabin issued a battle cry against the state's drug crisis, using his visit to signal the start of an aggressive... और पढ़ें

"No one can threaten me": MP Durai Vaiko hits back at former minister KN Nehru over remarks on his association with DMK

Tiruchirappalli, Sept. 18 -- MDMK Principal Secretary and Tiruchirappalli MP Durai Vaiko on Thursday hit back at former Tamil Nadu Minister KN Nehru over his reported remarks that he wanted to join th... और पढ़ें

Bangladesh open Asian Games hockey campaign with defeat

Dhaka, Sept. 18 -- Bangladesh held four-time champions South Korea at bay for the opening quarter before slipping to a 5-0 defeat in their first Asian Games hockey match. After a goalless first quart... और पढ़ें

Overseas Vietnamese entrepreneurs seen as bridge for Vietnam-US business ties

Washington DC, Sept. 18 -- Overseas Vietnamese entrepreneurs, with their understanding of both Vietnam and the US, can serve as a "two-way bridge", helping Vietnamese businesses access the US market w... और पढ़ें

Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, Sept. 18 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... और पढ़ें

Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, Sept. 18 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and... और पढ़ें

Singapore Clinical Trial: A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asciminib in pediatric participants newly diagnosed or previously treated with Philadelphia positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) with or without known T315I mutation.

Singapore, Sept. 18 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asci... और पढ़ें

Singapore Clinical Trial: A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with chemotherapy followed by asciminib plus blinatumomab in pediatric, adolescent, and young adult participants with relapsed or refractory BCR::ABL1-positive (Philadelphia positive, Ph+) or BCR::ABL1-like (Ph-like) acute lymphoblastic leukemia (ALL)

Singapore, Sept. 18 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib wit... और पढ़ें

• ««
• «
• 3493
• 3494
• 3495
• 3496
• 3497
• 3498
• 3499
• 3500
• 3501
• 3502
• »
• »»